ICTU Global Launch
UNEEG Medical Hyposafe System – An Exploratory Feasibility Study
First Site Initiated for GMRx2 ACT
GMRx2 ACT1 UK update
Imperial ranks second in the world in major university ranking
COVID-19 vaccination cuts infection risk by half in school-aged children - REACT
GMRx2 Placebo Controlled Trial (PCT)
ZODIAC trial presented at AHA
